Health & Biotech
Argent starts EU-GMP cannabinoid supply for drug resistant epilepsy at Slovenia’s largest hospital
Dr Boreham’s Crucible: ASX newbie Tetratherix plays it slow and steady
Health Check: Amid headwinds, Nanosonics goes bells and whistles on core device
Scott Power: ASX health lifts to start FY26, Tetratherix ends IPO drought
ASX June Health Winners: Sector falls 1.05pc but Amplia up 300pc after positive trial news
Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Vital Signs Podcast: Why this clinical-stage oncology company is “first in class”
Compumedics’ dual-helmet brain tech hits a nerve in China’s neuroscience boom
Neurizon inks global licensing deal with NYSE-listed Elanco
Health Check: Like bloodthirsty sharks, offshore acquirers are circling cheap biotech assets
EMVision makes progress in key trials for bedside brain scanner
Myriad soft-tissue reconstruction products position Aroa for strong growth
Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected
Health Check: And the EOFY biotech winner is … gasp … a pot stock
Optiscan begins breast cancer study in Melbourne
Trajan’s tech is enabling research into next-gen aviation fuels
Dr Boreham’s Crucible: ‘Better not louder’, Audeara is tuned in to the global audiology market
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
